dpp 4 glp 1 Differences between GLP-1 receptor agonists and DPP-4 inhibitors PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Biochim Biophys Acta 645:279292

Ansley DM, Wang B

This ultimately leads to genomic instability, cellular transformation, and tumorigenesis (54)

As for the patient base, a recent report found that 75% of patients stop taking the medications within two years, although the report did not elaborate on the causes of this decline in use, which may be partially attributable to factors such as high costs and self-funding requirements

Upregulation of microcirculation system of lens The microcirculation system of the lens provides a promising platform for improving nutrient and antioxidant delivery specifically to the lens nucleus

81973378, 82073909), Cultivate Scientific Research Excellence Programs of Higher Education Institutions in Shanxi (2019KJ022).This research project was supported by FSKSC and 1331KSC